Sherman Abrams Laboratory INC

Sherman Abrams Laboratory INC was paid $107.89M by Medicaid between Jan 2018 and Dec 2024, across 388 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 17% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New York

Rank by total paid#3 of 116

Median peer was paid$618K

This provider vs. median175×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	317,783	$3.18M
2019	446,789	$4.24M
2020	727,562	$12.84M
2021	1,328,435	$24.72M
2022	1,412,931	$26.43M
2023	1,653,797	$18.06M
2024incomplete	1,719,171	$18.42M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	17%	292,608	261,111	$18.01M
0202U	Oncology (prostate), multianalyte, gene expression profiling	11%	43,308	41,123	$11.48M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	8.7%	140,945	132,193	$9.40M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	7.8%	145,537	139,964	$8.45M
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	4.7%	225,442	193,097	$5.03M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	4.2%	227,124	203,687	$4.57M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.9%	200,382	198,270	$3.14M
86769		2.8%	109,143	102,284	$2.99M
87486		2.1%	193,039	183,658	$2.30M
87581		2.1%	192,854	183,500	$2.30M
80050	General health panel	1.7%	114,126	113,285	$1.79M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	1.4%	28,647	26,696	$1.54M

376 more codes

83036	Hemoglobin; glycosylated (A1C)	1.1%	238,788	$1.17M
80053	Comprehensive metabolic panel	1.1%	225,481	$1.15M
86480		<1%	34,011	$985K
80061	Lipid panel	<1%	269,773	$943K
82607		<1%	132,351	$908K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	74,515	$884K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	89,747	$872K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	73,566	$815K
84443	Thyroid stimulating hormone (TSH)	<1%	163,446	$779K
81408		<1%	1,229	$762K
87070		<1%	195,176	$742K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	18,839	$712K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	79,341	$710K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	49,730	$709K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	3,743	$708K
82670		<1%	45,953	$621K
86803		<1%	103,561	$553K
87340		<1%	108,140	$542K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	266,852	$518K
84144		<1%	52,581	$513K
84439		<1%	117,133	$508K
88142		<1%	45,736	$506K
87086	Culture, bacterial; quantitative colony count, urine	<1%	117,062	$447K
83002		<1%	48,806	$437K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	15,262	$434K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	1,733	$423K
82746		<1%	66,020	$409K
84153		<1%	42,316	$404K
87631		<1%	6,316	$403K
82728		<1%	59,256	$382K
87507		<1%	4,215	$376K
86706		<1%	77,072	$359K
86780		<1%	54,416	$330K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,660	$327K
86003		<1%	8,099	$319K
81001		<1%	186,387	$314K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	26,653	$285K
84403		<1%	20,598	$268K
86762		<1%	36,112	$264K
87506		<1%	2,207	$256K
86481		<1%	9,890	$255K
83001		<1%	27,224	$255K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	12,145	$244K
81422		<1%	1,516	$241K
84702		<1%	36,781	$231K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	17,520	$225K
83992		<1%	29,747	$221K
86765		<1%	33,150	$218K
88304		<1%	14,118	$216K
87634		<1%	16,757	$215K
88312		<1%	4,173	$203K
84481		<1%	36,424	$193K
86696		<1%	26,802	$191K
84480		<1%	65,553	$189K
80348		<1%	24,913	$186K
84146		<1%	17,789	$181K
86708		<1%	33,487	$179K
83540		<1%	71,048	$177K
86618		<1%	19,746	$172K
80364		<1%	21,702	$169K
80370		<1%	22,472	$169K
87184		<1%	40,838	$162K
87077		<1%	39,404	$160K
80337		<1%	19,448	$158K
86704		<1%	30,671	$156K
86787		<1%	33,001	$155K
84550		<1%	69,988	$153K
83013		<1%	5,474	$152K
86695		<1%	29,275	$149K
86735		<1%	30,866	$144K
82043		<1%	61,365	$139K
86376		<1%	18,858	$135K
80366		<1%	24,833	$129K
83550		<1%	52,869	$128K
80372		<1%	22,071	$127K
80354		<1%	24,320	$127K
80355		<1%	24,433	$124K
86665		<1%	9,100	$122K
80360		<1%	21,660	$120K
80373		<1%	21,710	$119K
80346		<1%	26,500	$114K
87660		<1%	14,855	$111K
80324		<1%	25,553	$111K
81412		<1%	262	$111K
80365		<1%	24,640	$111K
87517		<1%	5,117	$110K
80361		<1%	25,242	$109K
81161		<1%	1,561	$108K
83655		<1%	17,807	$108K
80356		<1%	24,286	$105K
81404		<1%	1,210	$105K
80358		<1%	25,309	$104K
80353		<1%	25,121	$103K
86141		<1%	18,049	$102K
87480		<1%	14,350	$100K
80359		<1%	24,429	$100K
81406		<1%	1,148	$99K
80367		<1%	22,158	$97K
81405		<1%	941	$96K
87510		<1%	13,802	$96K
84402		<1%	7,571	$95K
80368		<1%	19,623	$95K
81407		<1%	409	$90K
81513		<1%	2,893	$90K
82627		<1%	7,503	$85K
86592		<1%	44,655	$83K
88342		<1%	1,659	$82K
86235		<1%	8,997	$81K
83970		<1%	4,042	$80K
84436		<1%	56,314	$77K
80371		<1%	18,506	$76K
86160		<1%	6,730	$76K
83735		<1%	29,332	$73K
86617		<1%	5,055	$72K
88121		<1%	489	$71K
86800		<1%	9,950	$68K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	4,692	$64K
80048	Basic metabolic panel (calcium, ionized)	<1%	15,982	$63K
82570		<1%	29,258	$63K
88112		<1%	3,272	$62K
82747		<1%	9,923	$61K
86140		<1%	30,537	$60K
84154		<1%	4,895	$59K
83090		<1%	6,254	$57K
86644		<1%	9,176	$57K
88104		<1%	4,164	$56K
83516		<1%	5,099	$54K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	2,289	$52K
86431		<1%	18,248	$51K
84466		<1%	8,195	$49K
83020		<1%	8,140	$49K
86645		<1%	9,557	$48K
85652		<1%	44,012	$45K
83721		<1%	30,624	$45K
82668		<1%	4,549	$42K
87350		<1%	9,321	$42K
80349		<1%	10,313	$42K
81401		<1%	966	$42K
88141		<1%	7,351	$41K
86707		<1%	9,203	$41K
86060		<1%	14,878	$39K
82378		<1%	4,022	$39K
82105		<1%	10,333	$39K
82550		<1%	16,208	$39K
81400		<1%	1,607	$39K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	698	$39K
86038		<1%	11,742	$39K
87563		<1%	3,150	$38K
81257		<1%	1,267	$38K
80076		<1%	10,332	$37K
84445		<1%	1,790	$37K
87522	Neg quan hep c or qual rna	<1%	1,632	$36K
85730		<1%	13,232	$36K
80369		<1%	2,425	$36K
86200		<1%	5,417	$33K
85610		<1%	16,652	$32K
82785		<1%	4,548	$32K
82248		<1%	13,855	$31K
81243		<1%	1,651	$30K
86850		<1%	10,202	$30K
86901		<1%	21,182	$29K
82977		<1%	10,819	$28K
83690		<1%	9,324	$27K
86738		<1%	3,850	$27K
82150		<1%	11,133	$26K
84207		<1%	2,334	$25K
81250		<1%	1,266	$25K
86900		<1%	18,126	$25K
81015		<1%	32,103	$24K
81251		<1%	1,274	$24K
81255		<1%	1,271	$24K
86215		<1%	6,683	$23K
86304		<1%	2,406	$23K
83525		<1%	4,342	$23K
86225		<1%	6,661	$23K
82533		<1%	2,604	$23K
82784		<1%	4,645	$23K
81329		<1%	638	$22K
82947		<1%	12,490	$22K
84100		<1%	10,211	$22K
80321		<1%	2,615	$22K
81200		<1%	1,273	$22K
86664		<1%	3,463	$21K
87046		<1%	4,110	$21K
86301		<1%	2,056	$20K
81330		<1%	1,231	$19K
84270		<1%	2,142	$18K
81361		<1%	344	$18K
86777		<1%	2,891	$18K
83615		<1%	7,597	$18K
86778		<1%	2,851	$18K
80081		<1%	553	$17K
84479		<1%	27,279	$17K
82672		<1%	1,715	$17K
86747		<1%	1,708	$17K
86709		<1%	3,724	$17K
81290		<1%	1,278	$17K
83880		<1%	1,157	$17K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,459	$17K
83498		<1%	1,364	$16K
81260		<1%	1,276	$16K
82274		<1%	6,621	$16K
88120		<1%	184	$16K
81252		<1%	566	$16K
81209		<1%	1,277	$15K
87045		<1%	4,256	$15K
87081		<1%	6,082	$14K
83719		<1%	3,185	$14K
83520		<1%	1,988	$13K
81003		<1%	11,094	$13K
82465		<1%	5,868	$12K
83021		<1%	1,068	$12K
81374		<1%	1,214	$12K
87481		<1%	2,295	$11K
87511		<1%	1,565	$11K
87075		<1%	1,879	$11K
85660		<1%	5,833	$11K
84442		<1%	2,179	$10K
86300		<1%	939	$10K
88313		<1%	886	$10K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	1,432	$10K
86308		<1%	4,513	$10K
86663		<1%	1,814	$10K
87902		<1%	48	$10K
84165		<1%	2,266	$10K
80335		<1%	1,901	$9K
82166		<1%	695	$9K
86671		<1%	1,021	$9K
85651		<1%	6,076	$9K
36415	Collection of venous blood by venipuncture	<1%	31,962	$9K
84460		<1%	4,076	$9K
82626		<1%	654	$8K
81291		<1%	468	$8K
84450		<1%	4,076	$7K
83695		<1%	1,088	$7K
86705		<1%	1,771	$7K
82172		<1%	719	$7K
87177		<1%	1,539	$6K
80414		<1%	125	$6K
87529		<1%	432	$6K
87329		<1%	1,196	$6K
86364		<1%	965	$6K
87493		<1%	1,061	$6K
87220		<1%	1,359	$6K
82565		<1%	2,614	$6K
86258		<1%	867	$6K
86021		<1%	947	$5K
87209		<1%	1,500	$5K
87625		<1%	277	$5K
83921		<1%	418	$5K
84681		<1%	535	$5K
80350		<1%	1,019	$5K
86774		<1%	790	$5K
82247		<1%	3,049	$5K
82085		<1%	1,118	$4K
86757		<1%	322	$4K
88230		<1%	168	$4K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	727	$4K
85379		<1%	913	$4K
81242		<1%	368	$4K
84703		<1%	2,790	$4K
86256		<1%	854	$4K
83993		<1%	654	$4K
84075		<1%	1,902	$4K
84156		<1%	2,778	$4K
87338		<1%	1,005	$4K
86147		<1%	240	$4K
82310		<1%	1,729	$4K
86255		<1%	1,191	$4K
87109		<1%	703	$4K
86037		<1%	363	$4K
84155		<1%	3,367	$3K
84520		<1%	2,299	$3K
88262		<1%	65	$3K
87255		<1%	710	$3K
81596		<1%	176	$3K
86753		<1%	268	$3K
87476		<1%	250	$3K
83010		<1%	451	$3K
82270		<1%	1,563	$3K
84478		<1%	1,708	$3K
86692		<1%	277	$2K
83883		<1%	385	$2K
86039		<1%	686	$2K
86666		<1%	223	$2K
83003		<1%	151	$2K
82040		<1%	1,566	$2K
80178		<1%	660	$2K
82677		<1%	215	$2K
84305		<1%	227	$2K
86593		<1%	905	$2K
82553		<1%	440	$2K
86036		<1%	412	$2K
80320		<1%	431	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	534	$2K
86146		<1%	198	$2K
85045		<1%	896	$2K
83718		<1%	984	$2K
85041		<1%	1,310	$1K
84432		<1%	188	$1K
83519		<1%	176	$1K
82951		<1%	298	$1K
85014		<1%	1,155	$1K
85018		<1%	1,374	$1K
85044		<1%	692	$1K
84132		<1%	794	$1K
80177		<1%	349	$973.78
84425		<1%	108	$912.93
87101		<1%	305	$900.00
82024		<1%	56	$835.35
81025		<1%	515	$823.72
86702		<1%	145	$817.43
84315		<1%	576	$759.53
83704		<1%	50	$742.31
82950		<1%	419	$733.98
84163		<1%	119	$718.67
87341		<1%	169	$714.79
87536		<1%	13	$676.67
84295		<1%	619	$670.27
82642		<1%	58	$664.66
82140		<1%	93	$657.96
82374		<1%	639	$656.54
84252		<1%	60	$651.11
84446		<1%	80	$637.00
86336		<1%	181	$627.30
86360		<1%	23	$589.59
86382		<1%	61	$572.67
84482		<1%	134	$565.67
86701		<1%	147	$547.74
84590		<1%	95	$518.16
86611		<1%	44	$509.64
82435		<1%	599	$509.10
84630		<1%	111	$484.48
84597		<1%	62	$471.75
81508		<1%	32	$455.63
80164		<1%	46	$434.97
85384		<1%	112	$419.10
85613		<1%	102	$403.19
84166		<1%	84	$401.31
87168		<1%	529	$358.18
80069		<1%	83	$344.83
87469		<1%	29	$331.78
80051		<1%	95	$305.66
86648		<1%	35	$290.85
86870		<1%	26	$285.62
87530		<1%	48	$270.16
82952		<1%	266	$265.91
87468		<1%	28	$258.59
82180		<1%	48	$256.08
84300		<1%	123	$251.22
85732		<1%	84	$250.90
87040		<1%	58	$228.42
84484		<1%	48	$222.85
84540		<1%	146	$215.98
83986		<1%	507	$202.23
82985		<1%	31	$174.36
86335		<1%	15	$152.35
84560		<1%	101	$148.64
84133		<1%	65	$143.36
86162		<1%	15	$133.58
82436		<1%	58	$128.24
86812		<1%	12	$123.99
84378		<1%	21	$123.94
86231		<1%	27	$120.32
86334		<1%	12	$119.52
82656		<1%	43	$113.32
87484		<1%	14	$100.36
88300		<1%	12	$97.36
82552		<1%	15	$92.80
81383		<1%	13	$87.30
82397		<1%	16	$82.45
82390		<1%	12	$56.47
87324		<1%	16	$52.88
80345		<1%	16	$17.84
86886		<1%	12	$16.47
99080		0%	8,117	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEYBOVICH, YAKOV (CEO)